AF
CHRS icon

Advisornet Financial’s Coherus Oncology CHRS Stock Holding History

Advisornet Financial’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,040
Closed -$17K – 2035
2021
Q3 		$17K Sell
1,040
-415
-29% -$6.08K ﹤0.01% 1292
2021
Q2 		$20K Buy
1,455
+415
+40% +$5.88K ﹤0.01% 1217
2021
Q1 		$15K Hold
1,040
– – ﹤0.01% 1261
2020
Q4 		$18K Buy
+1,040
New +$18.5K ﹤0.01% 1148

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Advisornet Financial's CHRS Position: Q4 2021 in Review

Advisornet Financial sold out of Coherus Oncology (CHRS) in Q4 2021, closing a stake of 1,040 shares — an estimated $17K sold.

Advisornet Financial first reported a position in CHRS in Q4 2020 and held it in 4 quarters. The position peaked at $20K in Q2 2021. 201 funds tracked by Wall St. Rank hold CHRS as of Q4 2021.

  • Advisornet Financial reported no remaining Coherus Oncology position as of Q4 2021 after selling out during the quarter.
  • Advisornet Financial sold 1,040 Coherus Oncology shares in Q4 2021, an estimated $17K.
  • Advisornet Financial first reported a position in Coherus Oncology in Q4 2020 and held it in 4 quarters.
  • Advisornet Financial's Coherus Oncology position peaked at $20K in Q2 2021.
  • 201 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2021.

Based on Advisornet Financial's 13F filing for Q4 2021, filed 19 Jan 2022.